Hideaki Mizuno
BMC Medical Genomics · 2009–2012
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Whom Hideaki Mizuno trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Hideaki Mizuno overall
Papers from Hideaki Mizuno's perspective
Ordered by how strongly the researchers Hideaki Mizuno trusts endorse each paper. Same corpus, a different order for every researcher.
- NCBI GEO: mining tens of millions of expression profiles—database and tools update
- ArrayExpress—a public database of microarray experiments and gene expression profiles (Nucleic Acids Res.)
- Gene expression profiling predicts clinical outcome of breast cancer
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. (The Lancet)
- Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. (Journal of the National Cancer Institute)
- A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. (Cancer Cell)
- Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. (Cell)
- Oncogenic pathway signatures in human cancers as a guide to targeted therapies (Nature)
- Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. (Cell)
- When mutants gain new powers: news from the mutant p53 field (Nature Reviews. Cancer)
Their papers
- PrognoScan: a new database for meta-analysis of the prognostic value of genes (2009) — 890 citations
- Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. (2012) — 814 citations
- Mutant p53 Disrupts Mammary Acinar Morphogenesis via the Mevalonate Pathway (2012) — 810 citations